TO-O-1005

N/A

Report date: 2023/08/10 17:59:17
NME

Base Information

Drug NameTO-O-1005
Drug Alias NameTO-O-1005
ClassificationSmall molecules
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsPresbyopia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryTaiwan
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTheratocular Biotek Co Ltd
China Registration ClassN/A

Develop Information

Inactive CompaniesN/A
Active IndicationsPresbyopia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A